Skip to content
Division of Pulmonary & Critical Care Medicine
Division of Pulmonary & Critical Care Medicine Henry Ford Health System
  • Schedules
  • Conferences
  • Curriculum
  • PFTs
  • moonlighting
  • Residents
  • NIPPV
  • K17
  • Clinical Trials
  • Newsletter

Tag: epoprostenol


Inhaled epoprostenol and inhaled nitric oxide use for COVID positive patients with ARDS

Posted on February 11, 2021February 11, 2021 by Michael Lazar
Updated on February 11, 2021

– Here are the policy and PowerPoint which contains education on inhaled epoprostenol and inhaled nitric oxide use for COVID positive patients with ARDS.  – The PowerPoint has audio embedded in it.– The policy will be “live” on 2/17/21.

Read More

Search all posts

Login here:

  • ICU
  • Research projects
  • Research Curriculum
  • ILD/PH
  • WP admin

Presentations & Reading

  • Journal Club
  • Pulmonary / Critical Care Lecture Repository
  • Friday Presentations (Pre-2022)
  • ATS Reading List

Other Links

  • Triage instructions
  • RPO
  • For Applicants
  • Interventional Pulmonology
  • Patient tracker
  • PCCM Reports
Division of Pulmonary & Critical Care Medicine | Powered by Brisko WordPress Theme